Navigation Links
Allos Therapeutics Reports Third Quarter 2007 Financial Results
Date:11/5/2007

WESTMINSTER, Colo., Nov. 5 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH) today reported financial results for the third quarter of 2007. For the three months ended September 30, 2007, the Company reported a net loss of $9.3 million, or ($0.14) per share. This compares to a net loss of $8.1 million, or ($0.15) per share, for the third quarter of 2006. For the nine months ended September 30, 2007, the Company reported a net loss of $28.1 million, or ($0.43) per share, compared to a net loss of $22.1 million, or ($0.40) per share for the same period last year. For the nine months ended September 30, 2007, net cash used in operating activities was $22.5 million. Cash, cash equivalents and investments in marketable securities as of September 30, 2007 were $63.4 million.

"With five PDX trials ongoing and two additional studies scheduled to begin in the near term, we continue to make important progress advancing the development of PDX in hematologic malignancies and solid tumors," stated Paul L. Berns, President and Chief Executive Officer of Allos. "PROPEL, our pivotal Phase 2 trial of PDX in patients with relapsed or refractory peripheral T-cell lymphoma, is ahead of schedule with completion of patient enrollment expected in the second quarter of 2008. We look forward to providing future updates regarding PDX's clinical profile and potential commercial opportunities."

Pipeline Development Update:

PDX (pralatrexate)

PDX is a novel, small molecule chemotherapeutic agent that inhibits dihydrofolate reductase, or DHFR, a folic acid (folate)-dependent enzyme involved in the building of nucleic acid, or DNA, and other processes. PDX is an investigational drug currently under evaluation
'/>"/>

SOURCE Allos Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference
2. Prime Therapeutics Receives TIPPS Certification
3. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
4. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
5. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
6. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
7. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
8. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
9. Prime Therapeutics Announces URAC Accreditation
10. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
11. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... DriButts, a non-profit organization ... Slingshot® Product Development Group to manufacture a long-lasting reusable diaper for warm weather ... plans to bring 600 DriButts Diapers to rural areas of Haiti during a ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... care community to be situated at 4400 Columbine Drive in Bellingham, Washington. Silverado ... 2016, and has been carefully designed to serve up to 80 people living ...
(Date:9/3/2015)... ... September 03, 2015 , ... Today, Splashtop ... Suite customers, as part of the LANDESK One Partner program. Splashtop ... the best mobile user experience in remote access and control:, ...
(Date:9/3/2015)... Monroe, NC (PRWEB) , ... September 03, 2015 , ... ... 2015, 6:30pm-9:30pm at the beautiful Morning Glory Farm, 6205 Kate Road in Monroe, North ... Whether an event is a corporate or social function, Kate Clyde’s offers off-premise catering ...
(Date:9/3/2015)... ... 2015 , ... B. E. Smith, the only full-service leadership ... national chief executive officer recruitment for Melissa Memorial Hospital in Holyoke, ... E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
Breaking Medicine News(10 mins):Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3
... Oct. 20 Heifer International, http://www.heifer.org, a ... for the green-minded client, the hard-to-shop-for,person who says, ... budgets.,Heifer focuses on doing one thing well: Helping ... living on less than $2 a day gain ...
... Ride Home" , ... Alameda, California (PRWEB) October 20, 2008 -- Alameda-based ... of holidays for the Safe and Sober Free Cab Ride Home program. ... in Alameda and Luxor Cab in San Francisco to provide free transportation ...
... Compound is a member of PPI class for treatment for GERD and ... ... Takeda Pharmaceutical Company,Limited ("Takeda") today announced that Takeda Global Research and,Development ... U.S. Food and Drug Administration (FDA) that,the agency will not be able ...
... Ice to Hydrate and Soothe Young Throats, ... cold season,rapidly approaches, Integrated Beverage Group, Ltd. (IBG), ... launched its newest,product -- Children,s Throat Cooler(R). This ... parents who wish to choose a 100%,drug free ...
... the U.S., approximately one,in eight couples of childbearing age ... a fertility specialist for help trying to conceive,(source: CDC)., ... any woman who,wants to keep herself healthy so she ... Conceive,s readers are thinking about family building,and the new ...
... The Westaim Corporation,announced today a purchase and ... Technology Ltd. and CTS Group Limited. Under ... and intellectual property,for net proceeds of approximately ... conditions, including iFire obtaining certain Government of ...
Cached Medicine News:Health News:Heifer International: The Greener Good for Holiday Giving 2Health News:Free Cab Rides Home for Halloween in Alameda, Oakland, Berkeley and San Francisco, California 2Health News:Free Cab Rides Home for Halloween in Alameda, Oakland, Berkeley and San Francisco, California 3Health News:FDA Adds Three Months to Review of Takeda's New Drug Application for TAK-390MR 2Health News:Integrated Beverage Group Launches Children's Throat Cooler(R) 2Health News:Integrated Beverage Group Launches Children's Throat Cooler(R) 3Health News:Conceive Magazine Introduces a Special Issue: 'The Birds, The Bees, and Modern Medicine' 2Health News:Westaim announces sale of iFire Technology Ltd. assets 2
(Date:9/3/2015)... COPENHAGEN, Denmark , Sept. 3, 2015 ... ), a clinical stage biotechnology company that ... significant unmet medical needs, today announced plans ... , 2015 Wells Fargo Healthcare Conference in ... 1:55pm EDTEvent: , Bank of America Merrill ...
(Date:9/3/2015)... Research and Markets( http://www.researchandmarkets.com/research/fw4ctl/investigation ... Report on China,s Entecavir Market, 2010-2019" report to ... with hepatitis B virus (HBV) exceeds 100 million in ... suffering from chronic Hepatitis B. About 0.5 million Chinese ... cancer caused by chronic Hepatitis B, causing a loss ...
(Date:9/3/2015)... 3, 2015  Abaxis, Inc. (NasdaqGS: ABAX ), ... consumables to the medical, research and veterinary markets, announced ... will present at the CL King 13 th ... 2015 at 11:00 a.m. ET. The conference will be ... New York City . Abaxis, ...
Breaking Medicine Technology:Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2China Entecavir Market Report 2010-2019 2
... NeuroDiscovery Ltd (ASX:,NDL), a specialty neuroscience service ... Corporation ("Sosei"; TSE Mothers Index: 4565), a ... presenting further pivotal pre-clinical efficacy data for ... for neuropathic pain and has,successfully completed Phase ...
... Nov. 18 Arlington Medical Resources (AMR), a,provider of ... finds that over $10 million of CSL Behring,s Privigen ... 2008. Privigen is the newest,brand of intravenous immune globulin ... IVIG is a product created from the blood plasma ...
Cached Medicine Technology:Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2
... (also known as the VOCARE) Bladder System ... used by people with spinal cord injuries ... demand. A secondary use of the device ... promote penile erection.,The Bladder System includes surgically ...
Used for dilation of a tract to the kidney for removal of stones. Supplied sterile in peel-open packages. Intended for one-time use....
Used for dilation of a tract to the kidney for removal of stones. Supplied sterile in peel-open packages. Intended for one-time use....
... to dilate the musculofascial tract, renal capsule, ... balloon contours to the catheter shaft. Radiopaque ... distal ends of the balloon. The radiopaque ... catheter to allow coaxial placement of the ...
Medicine Products: